The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy | Pharmacology & Therapeutics | 2015 | 110 |
Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction | Hepatobiliary Surgery and Nutrition | 2015 | 68 |
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis | DMM Disease Models and Mechanisms | 2015 | 42 |
Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients | Journal of Gastroenterology and Hepatology (Australia) | 2015 | 40 |
Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2 | PLoS ONE | 2015 | 40 |
Non-polypoid colorectal neoplasms: Classification, therapy and follow-up | World Journal of Gastroenterology | 2015 | 37 |
Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome | Chronobiology International | 2015 | 31 |
Usefulness of thromboelastometry in predicting the risk of bleeding in cirrhotics who undergo invasive procedures | European Journal of Gastroenterology and Hepatology | 2015 | 30 |
Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? | Journal of Cardiovascular Medicine | 2015 | 20 |
Polidocanol injection decreases the bleeding rate after colon polypectomy: a propensity score analysis | Gastrointestinal Endoscopy | 2015 | 19 |
Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet | International Journal of Obesity | 2015 | 19 |
Echoendoscopic ethanol ablation of tumor combined to celiac plexus neurolysis improved pain control in a patient with pancreatic adenocarcinoma | Endoscopic Ultrasound | 2015 | 17 |
ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy | Biomedicine and Pharmacotherapy | 2015 | 12 |
Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region) | Journal of Gastroenterology and Hepatology (Australia) | 2015 | 12 |
Rapid small intestinal permeability assay based on riboflavin and lactulose detected by bis-boronic acid appended benzyl viologens | Clinica Chimica Acta | 2015 | 11 |
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients | Journal of Viral Hepatitis | 2015 | 11 |
Combination therapy with sorafenib and radiofrequency ablation for hepatocellular carcinoma: a glimmer of light after the storm trial? | American Journal of Gastroenterology | 2015 | 7 |
Neuropeptide S inhibits gastrointestinal motility and increases mucosal permeability through nitric oxide | American Journal of Physiology - Renal Physiology | 2015 | 7 |
Superior digestive tract side effects after prolonged treatment with NSAIDs in patients with osteoarthritis | Journal of Medicine and Life | 2015 | 7 |
Multifocal Gastrointestinal Angiosarcoma: a Challenging Diagnosis? | Journal of Gastrointestinal and Liver Diseases | 2015 | 4 |
Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases? | American Journal of Gastroenterology | 2015 | 3 |
Medical Systemic Therapies for Hepatocellular Carcinoma: Clinical Perspectives and Safety Profile | Current Drug Safety | 2015 | 3 |
Symptomatic Gallbladder Sludge and its Relationship to Subsequent Biliary Events | Journal of Clinical Gastroenterology | 2015 | 2 |
Letter: prognostic scoring systems for hepatocellular carcinoma patients--the jury is still out | Alimentary Pharmacology and Therapeutics | 2015 | 1 |
What is the optimal treatment for hepatic abscess and infected biloma? | Gastrointestinal Endoscopy | 2015 | 1 |